Taking lessons from dendritic cells: multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunity
- 16 November 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (11) , 1835-1844
- https://doi.org/10.1038/sj.gt.3301016
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 39 references indexed in Scilit:
- Anti-tumor immunity generated by tumor cells engineered to express B7-1 via retroviral or adenoviral gene transferCancer Letters, 1998
- Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathwayEuropean Journal of Immunology, 1998
- Generation of dendritic cell‐like antigen‐presenting cells in long‐term mixed leucocyte culture: phenotypic and functional studiesImmunology, 1997
- Cloning of the mucosal addressin MAdCAM‐1 from human brain: Identification of novel alternatively spliced transcriptsImmunology & Cell Biology, 1996
- Rapid induction of tumor necrosis factor cytotoxicity in naive splenic T cells by simultaneous CD80 (B7.1) and CD54 (ICAM‐1) co‐stimulationEuropean Journal of Immunology, 1996
- Co‐expression of B7‐1 and ICAM‐1 on tumors is required for rejection and the establishment of a memory responseEuropean Journal of Immunology, 1995
- Molecular Cloning of Human E-Cadherin Suggests a Novel Subdivision of the Cadherin SuperfamilyBiochemical and Biophysical Research Communications, 1994
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways.The Journal of Experimental Medicine, 1991
- Human melanoma cells with high susceptibility to cell‐mediated lysis can be identified on the basis of icam‐1 phenotype, vla profile and invasive abilityInternational Journal of Cancer, 1990